Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Treatment of Idiopathic calcium stone disease.

Danielson BG, Pak CY, Smith LH, Vahlensieck W, Robertson WG.

Calcif Tissue Int. 1983 Sep;35(6):715-9. No abstract available.

PMID:
6652545
2.

The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.

Pak CY, Nicar M, Northcutt C.

Contrib Nephrol. 1982;33:136-51. Review. No abstract available.

PMID:
6749417
3.

Medical management of nephrolithiasis.

Pak CY.

J Urol. 1982 Dec;128(6):1157-64. No abstract available.

PMID:
6759686
4.

Management of the stone former.

Burns JR, Finlayson B.

Semin Urol. 1984 Feb;2(1):34-44. No abstract available.

PMID:
6463460
5.

Medical and surgical aspects of urinary stone disease.

Burns JR.

Ala J Med Sci. 1985 Jan;22(1):68-71. Review. No abstract available.

PMID:
3883830
6.

Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.

Tiselius HG; Advisory Board of European Urolithiasis Research and EAU Health Care Office Working Party for Lithiasis.

BJU Int. 2001 Jul;88(2):158-68. Review. No abstract available.

7.

Mechanism of allopurinol action in calcium oxalate stone formers.

Tomlinson B, Al-Khader A, Cohen SL, Kasidas GP, Krywawych S, Edgar L, Rose GA.

Proc Eur Dial Transplant Assoc. 1981;18:556-60. No abstract available.

PMID:
6276882
8.
9.

[Medical treatment of idiopathic calcium lithiasis (II)].

Bataille P, Finet M, Renaud H, Fievet P, Rogez JC, Fournier A.

Nephrologie. 1985;6(4):195-202. Review. French. No abstract available.

PMID:
2418378
10.

Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.

Osborne CA, Poffenbarger EM, Klausner JS, Johnston SD, Griffith DP.

Vet Clin North Am Small Anim Pract. 1986 Jan;16(1):133-70. Review.

PMID:
3518199
11.

Pharmacologic treatment of uric acid calculi.

Preminger GM.

Urol Clin North Am. 1987 May;14(2):335-8.

PMID:
3576854
12.

Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.

Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G.

Clin Sci (Lond). 1997 Sep;93(3):257-63.

PMID:
9337641
13.

[Therapy of nephrolithiasis].

Tschöpe W, Ritz E.

Dtsch Med Wochenschr. 1985 Mar 8;110(10):385-8. German. No abstract available.

PMID:
3971867
14.

Kidney stones. Medical management and newer options for stone 'removal'.

Kanig SP, Conn RL.

Postgrad Med. 1985 Nov 1;78(6):38-44, 47-51.

PMID:
4059131
15.

[Medical treatment of idiopathic calcium lithiasis (I)].

Bataille P, Finet M, Renaud H, Fievet P, Rogez JC, Fournier A.

Nephrologie. 1985;6(2):75-7. Review. French.

PMID:
3895012
16.

[Conservative treatment of kidney calculi].

Dworschak W, Haschek H.

Med Klin. 1969 Feb 14;64(7):273-8. German. No abstract available.

PMID:
5769478
17.

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.

J Urol. 2003 Feb;169(2):465-9.

PMID:
12544288
18.

[Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].

Musialik D, Głuszek J, Pieczyńska A.

Pol Tyg Lek. 1991 Oct 7-21;46(40-42):739-42. Polish.

PMID:
1669148
19.

New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate.

Lake KD, Brown DC.

Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):530-9. Review.

PMID:
3896714
20.

[Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].

Butz M.

Urologe A. 1982 May;21(3):142-6. German.

PMID:
7048691
Items per page

Supplemental Content

Write to the Help Desk